Describes motivation process for creativity with emphasis on intrinsic motivation by Corey K Katir

New results show important steps being made to improve the diagnosis and treatment of malignant pleural mesothelioma, an aggressive cancer of the outer lining of the lungs caused by asbestos exposure.

Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer — mesothelioma, and melanoma of the eye. Additionally, when these individuals are exposed to asbestos or similar mineral fibers, their risk of developing mesothelioma, an aggressive cancer of the lining of the chest and abdomen, is markedly increased.

Vehicles traveling along gravel roads in Dunn County, North Dakota stir up clouds of dust containing high levels of the mineral erionite. Those who breathe in the air every day are at an increased risk of developing mesothelioma, new research shows. Erionite shares similar physical similarities with asbestos and when airborne, its fibers can lodge in people’s lungs. Over time, the embedded fibers can lead to mesothelioma, a lung cancer most often associated with asbestos.

Pleural mesothelioma patients who undergo lung-sparing surgery in combination with photodynamic therapy (PDT) show superior overall survival than patient treated using the conventional therapy of extrapleural pneumonectomy (or en bloc removal of the lung and surrounding tissue) with PDT, indicates new research.

A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a new study.

New data shows that people exposed to the mineral erionite found in the gravel of road materials in North Dakota may be at significantly increased risk of developing mesothelioma, a type of lung cancer most often associated with asbestos exposure.

Using a novel aptamer-based proteomics array technology, researchers and collaborators have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage for two of the most aggressive and deadly forms of cancer — pancreatic and mesothelioma.

More than 20 million people in the US, and many more worldwide, who have been exposed to asbestos are at risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen that is resistant to current therapies. Moreover, asbestos exposure increases the risk of lung cancer among smokers. For the past 40 years researchers have tried to understand why asbestos causes cancer.

Researchers have demonstrated the safety of a potential vaccine against mesothelioma, a rare cancer associated primarily with asbestos exposure. The vaccine, which infuses uses a patient’s own dendritic cells with antigen from the patient’s tumor, was able to induce a T-cell response against mesothelioma tumors.

In the USA each year, 200,000 cancer patients suffer from a malignant pleural effusion — development of excessive fluid (pleural effusion) in the chest. Several litres of such fluid can accumulate, and many patients suffer from significant breathlessness and distress. One in four patients with lung cancer, one in every three with breast cancer and most of the patients with mesothelioma will develop a malignant effusion. The current strategy is to induce a pleurodesis (seal the pleural cavity with a chemical agent so no fluid can accumulate). However existing agents are far from perfect, with most producing significant side effects while delivering low success rates.

A new technique may help clinicians hone in on a diagnosis in patients presenting with a pleural effusion of unknown cause.

A four-gene expression ratio test prospectively distinguished mesothelioma patients who had a statistically significant longer overall survival from those who had shorter survival in a single-institution study.

Scientists are now studying the molecular underpinnings of cancer by probing individual bonds between an asbestos fiber and human cells. Though any clinical application is years away, the researchers hope their findings could aid in drug development efforts targeting illnesses caused by excessive exposure to asbestos, including the deadly cancer called mesothelioma.

The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung’s lining that is almost always caused by previous exposure to asbestos.

Scientists have established a mouse model for human malignant mesothelioma that will provide valuable insight into cancer development and progression along with new directions for design of therapeutic strategies. The research may eventually lead to a substantially improved outlook for patients with this devastating disease. Malignant mesothelioma is an aggressive cancer originating from the mesothelial lining of the pleural cavity and is associated with asbestos exposure and is characterized by a long latency period between exposure and disease onset.

People with mesothelioma — a form of cancer associated with asbestos exposure — have a higher survival rate when treated with a combination of two cancer drugs, a large multicenter study finds.

High exposure to a fibrous volcanic mineral called erionite was associated with a high incidence of a type of cancer called mesothelioma, according to a study in the March 15 issue of the Journal of the National Cancer Institute.

Researchers at New York University School of Medicine and Wayne State University have found a molecule that reveals the early stages of pleural mesothelioma, a chest cancer caused by asbestos. The finding opens the way to a blood test for the disease, according to a new study published in the Oct. 13 issue of The New England Journal of Medicine.

Everyday exposure to naturally occurring asbestos increases the risk of developing malignant mesothelioma, according to a study by UC Davis researchers. The study – the largest to examine the question – will be published this fall in the American Journal of Respiratory and Critical Care Medicine.

A study, published in the September 25 issue of Lancet, calls into question the proposed link between SV40 and pleural mesothelioma and provides a possible explanation for the discrepancies in the results obtained by different groups.

Personal Injury Lawyer Los Angeles – FREE CONSULTATION by Personal Injury Attorney Los Angeles – Legal Defenders, Los Angeles Personal Injury Lawyers – Law Offices of Burg and Brock, who have won over $100 million in verdicts and settlements for clients

Page took 2 seconds to load.